… biologic in Europe for respiratory diseases, with a twice-yearly … durable control with less treatment burden,” said Kaivan Khavandi … raised blood eosinophils despite treatment with inhaled triple therapy … the MATINEE phase three trial, which showed a …

… an add-on maintenance treatment for uncontrolled chronic … double-blind, parallel-group trial assessing the efficacy and … deliver more ambitious treatment goals, develop the next generation … millions of people with respiratory diseases. With an industry-leading …

… . Within this category, treatments for asthma and COPD, … cancers, respiratory diseases, reproductive issues, and neurological disorders. Pharmatrac’s report … “This is why these drugs are being prescribed more … warn that respiratory drug demand may continue …

… most prevalent chronic respiratory diseases worldwide, affecting … relies on inhaled medications, including inhaled corticosteroids … analysis. Eur Rev Med Pharmacol Sci. 2021; … development of tezepelumab for the treatment of asthma. Expert Opin Drug …

… as well as major pharmaceutical milestones that have introduced … patients receiving no treatments or incorrect treatment,” they wrote. … supporting the increase of respiratory disease screening is perhaps the … to altogether prevent COPD development in at-risk …

… treating diseases and prolonging life. The demand for new drugs to treat … organisms due to medication. These techniques, … and the development of new treatments. For instance … Respiratory Disease, Other Therapeutic Areas 5) By End User: Pharmaceutical …

… many respiratory diseases like influenza, respiratory syncytial virus, and more. However, pharmacists’ knowledge … rates. Drug Topics: Are there concerns among pharmacists regarding the constant development of …

… developed. The prime minister also announced that the range of medications … will include medications for outpatient treatment of cardiovascular … diseases from 2026, gastrointestinal diseases from 2028, and respiratory diseases …

… development of novel therapies to improve the lives of people with respiratory diseases … ENaC blockers, the pharmacokinetic profile of ETD001 … trial (NCT06478706) investigating whether 28 days of treatment … new therapies to treat mucus obstruction in …

… treatment of CVA and may underpin the development … of CVA and other respiratory diseases. These alterations primarily … TCM formulas in treating complex diseases through … nonsteroidal anti-inflammatory drug-exacerbated respiratory disease. J Allergy Clin …